A Bcr/Abl-independent, Lyn-dependent Form of Imatinib Mesylate (STI-571) Resistance Is Associated with Altered Expression of Bcl-2
Open Access
- 1 August 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (33), 34227-34239
- https://doi.org/10.1074/jbc.m402290200
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cellsOncogene, 2003
- Lyn regulates the cell death response to ultraviolet radiation through c-Jun N terminal Kinase-dependent Fas ligand activationExperimental Cell Research, 2003
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Bcl-2 Independence of Flavopiridol-induced ApoptosisPublished by Elsevier BV ,2000
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cellsOncogene, 2000
- Transformation of Myeloid Leukemia Cells to Cytokine Independence by Bcr-Abl Is Suppressed by Kinase-defective HckPublished by Elsevier BV ,2000
- Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XLThe Journal of Experimental Medicine, 2000
- A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma CellsPublished by Elsevier BV ,2000